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There has been controversy regarding the clinical utility of fecal occult blood test (FOBT) as a screening 
tool for colorectal cancer (CRC) in the general population. The purpose of this study was to examine 
the results of Korea national CRC screening using FOBT from 2006 to 2013 and to evaluate the 
implementation of the program. We analyzed the results of FOBT, colonoscopy, and the side effects 
during colonoscopy for the subjects (n = 20,609,909) from the Korea National Health Insurance Cancer 
Screening database. For evaluation of Korea national CRC screening program implementation over 
the 8-year period, we calculated uptake rate, FOBT positivity rate, and subsequent test compliance 
rate. The overall uptake rate was 30.1%, with an increasing pattern from 2006 to 2011. A relatively 
higher FOBT positivity rate (6.4%) and lower subsequent test compliance rate (46.6%) were observed 
in comparison to the results previously reported in Western countries. Side effects reported within 3 
months period after colonoscopy accounted for 0.17% of all procedures, with bleeding being the most 
prevalent type. Although the implementation of CRC screening program using FOBT in Korea seems 
successful, trends in key indicators for Korea national CRC screening program should be monitored 
continuously.
Colorectal cancer (CRC) is the third most common cancer in South Korea after thyroid and gastric cancers1. In 
2011, the age-standardized incidence rates of CRC were 51.4/100,000 males and 26.4/100,000 females, and the 
rates continue to increase. When this age-standardized incidence is compared with those of Japan, the United 
States, and United Kingdom, Korea shows the highest incidence of CRC in both males and females2. Even though 
Korea is considered to be a developed Asian country, the high consumption of red meat or alcohol, and obesity 
have been suggested as causes of the elevated risk of CRC in Koreans. As a result, the Korean Ministry of Health 
and Welfare implemented a national cancer screening program for five major cancers (stomach, liver, colorectal, 
breast, and cervical cancer)3. The national CRC screening began in 2004 and required all Korean individuals older 
than 50 years of age. This program was covered by national health insurance for all participants to undergo fecal 
occult blood test (FOBT) biannually until 2011 and annually starting in 2012.
Researchers in many countries, including Scotland4, Germany5, United Kingdom6, France7, Italy8, Canada9, 
Croatia10, Spain11, and Finland12 have published the results of national CRC screening by various screening strat-
egies such as FOBT, colonoscopy, and sigmoidoscopy. Although few reports have studied the results of national 
CRC screening programs for Asian populations13, 14 or the Korean population15–17, a relatively small size and short 
period have been limitations in comparison to reports from Western Caucasian populations.
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At the same time, various diagnostic tools were assessed to optimize the most cost-effective screening method. 
Since FOBT is historically preferred, several randomized controlled trials have demonstrated the efficacy of CRC 
screening using the FOBT through the illustration of 15–33% reduced mortality rates18–20. However, there are 
recent reports doubting the clinical utility of mortality reduction due to FOBT21, 22.
Herein, we report the results of the Korea national CRC screening by FOBT for 2006–2013, which is the larg-
est dataset ever analyzed. We evaluated the implementation of the national CRC screening program in Korea by 
analyzing key performance indicators. Primary objective was to determine outcome parameters of uptake rate, 
FOBT positivity rate, and subsequent test compliance rate. Secondary objective was to investigate the rate of 
side effects during colonoscopy and possibly the presumptive positive predictive value of FOBT. We also deter-
mined the diagnostic significance of FOBT for CRC and compared colonoscopy results with those in reports from 
Western countries.
Methods
Study population. The cancer screening program is conducted at the national level by the Korean Ministry 
of Health and Welfare and targets adults older than 50 years of age among medical aid beneficiaries and national 
health insurance subscribers. All of the eligible population within the framework of the national CRC screening 
program receives an invitation letter from the National Health Insurance Corporation (NHIC) at the beginning 
of each calendar year. All of these examinations within the national screening program were performed free of 
charge at a clinic or hospital designated as a CRC screening unit by the NHIC. Among the target population from 
2006 to 2013, the results of individuals who voluntarily participated in the CRC screening program were included 
in the study after eliminating erroneous results. Erroneous results were defined as missing values, incorrectly 
entered numbers, and discrepant data. Demographic information, results of FOBT, results of further evaluation 
[i.e., colonoscopy or double-contrast barium enema test (DCBE)] if performed, and side effects during colonos-
copy were obtained from the Korea National Health Insurance Cancer Screening database.
Screening protocol. During an 8-year study period, the FOBT was consistently performed as the primary 
screening method. However, different principles of FOBT including qualitative immunochemical and quantita-
tive guaiac tests were utilized according to availability in visited test centers, because the test centers were scat-
tered throughout the country and changed during the study period (i.e., quantitative: 64.5%, qualitative: 35.5%).
A flow chart of the hierarchical CRC screening protocol is described in Supplementary Fig. 1. For the par-
ticipants with positive FOBT result, colonoscopy or DCBE was conducted as an additional screening test. When 
colonoscopy found an abnormal result, a biopsy was performed with the polyp removal during the colonoscopy 
procedure, if indicated. Although the quality of colonoscopy performance by various doctors could not be real-
istically standardized, abnormal findings in colonoscopy were classified into three categories of polyp, suspicious 
cancerous lesion, and definitive cancerous lesion (i.e., cancer). Suspicious cancerous lesions were subjectively 
judged and recorded, based on the medical interpretation of colonoscopic findings by the performing physicians. 
The term “suspicious cancer lesions” were categorized in the database to express wide spectrum between defini-
tive polyp and definitive cancer, possibly including inflammatory or high-grade dysplastic lesions that required 
further biopsy procedure.
Definitions of evaluation parameters. To evaluate the Korea national CRC screening program imple-
mentation during an 8-year period, we calculated three key performance indicators suggested by the previous 
study4.
Uptake rate (UR, %): Number of FOBT participants/Number of eligible individuals for national CRC screen-
ing program;
FOBT positivity rate (FPR, %): Number of positive FOBT results/Number of FOBTs performed;
Subsequent test compliance rate (SCR, %): Number of colonoscopy or DCBE procedures performed/Number 
of positive FOBT results;
For the evaluation of FOBT diagnostic performance, the predictive value of positive tests (PPV) of FOBT for 
polyp, suspicious cancerous lesion, and cancer were analyzed. Unfortunately, we were unable to calculate the sen-
sitivity and specificity due to lack of a proper control group. Additionally, it is important to remind that the calcu-
lated PPV in this study does not meet the strictly ideal PPV values which require histopathological determination 
by biopsy, due to lack of the appropriate data in the Korea National Health Insurance Cancer Screening database.
PPV: Number of abnormal lesions confirmed by colonoscopy or DCBE/Number of positive FOBT results.
For the evaluation of colonoscopy procedural performance, we analyzed the occurrence of side effects during 
the colonoscopy procedure. The side effects were classified into four categories of bleeding, perforation, infection, 
and others.
Rate of side effects associated with colonoscopy (SER, %): Number of side effects reported within 3 months 
period after the procedure/Number of colonoscopy procedures performed.
For detection of each category for side effects, we used Korean National Health Insurance Service (KNHIS) 
database to look up for the Korean Classification of Diseases (KCD) codes within 3 months period after colo-
noscopy. In Korea, all citizens are obligated to enroll in the KNHIS. Since all medical providers are required to 
submit claims to KNHIS, no health care records are duplicated or omitted using KCD similar to the International 
Classification of Diseases (ICD) for diagnostic codes. “Bleeding” included KCD codes of hemorrhage and hemat-
oma, whereas “perforation” included those of injury, traumatic perforation, or accidental perforation in all parts 
of colon. “Infection” included KCD codes of infection following a procedure, while “others” represented those of 
air embolism, shock resulting from a procedure, and complications of surgical and medical care.
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Statistical analysis. Results of FOBT, colonoscopy or DCBE, and biopsy were analyzed by medical statistics 
specialists (TY et al.). Categorical variables regarding the effects of gender and year on each parameter were com-
pared using the Chi-square test, whereas numerical variables were compared using the t-test. A P < 0.05 was con-
sidered statistically significant. All statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, 
NC, USA), MedCalc version 12.7 (MedCalc Software, Ostend, Belgium), and SPSS version 20.0 for Windows 
(IBM Corp., Armonk, NY, USA).
Ethics. This study design was reviewed and approved by the Institutional Review Board of the National Health 
Insurance Service Ilsan Hospital, Gyeonggi-do, Korea. Written informed consent was waived. Additionally, all 
experiments and methods in this study were performed in accordance with the Declaration of Helsinki.
Results
Characteristics of the study population. After the elimination of erroneous results (n = 2,489), the 
results of a total of 20,609,909 individuals who participated in the CRC screening program were included in the 
study (Table 1). Female participants were more than male participants in the study population (i.e. 55.0% vs. 
45.0%). Although the youngest age group (50–59 years old) accounted for 45.7% of the total population, no one 
age group represented more than 50% of the study population. Considering the years of the CRC screening pro-
gram, the number of FOBT participants increased gradually throughout the study period.
Evaluation of the Korea national CRC screening program implementation. The changes in UR 
over the studied years are shown in Fig. 1a. A continuous increase in UR was observed from 2006 to 2011, chang-
ing from 19.5% to 36.8%. Due to the time interval change in FOBT uptake from every other year to every year 
in 2012, the target population increased dramatically in 2012 and 2013 compared to previous years. When this 
change of national CRC screening program on frequency for FOBT uptake was considered, a similar increase in 
total UR was observed in 2012–2013, changing from 28.2% to 32.1%. Consistently, the UR of females was higher 
than that of males in all years.
The total FPR ranged from 5.9% to 7.7% in 2006–2013 and did not show significant trend by year or type of 
FOBT (quantitative or qualitative). However, FPR was consistently higher in males than females in all years with 
statistical significance (P < 0.001), resulting in higher total mean FPR in males (7.5%) than in females (5.5%) 
(Fig. 1b). FPR also continuously increased in the older age groups for both genders.
Even though the overall SCR was 46.6%, the SCR of males was higher than that of females in all years (Fig. 1c). 
Interestingly, there was rising peak of SCR in year 2012 among the decreasing trend in both genders.
Evaluation of FOBT diagnostic performance. The PPVs of FOBT for polyp, suspicious cancerous 
lesion, and cancer were 21.4%, 42.6%, and 1.3%, respectively, when abnormal lesions were determined by colo-
noscopy or DCBE results (Table 2). While PPVs were higher in males than in females for suspicious cancerous 
lesion and cancer, PPV for polyp was higher in females than in males. When age was considered, PPVs for sus-
picious cancerous lesion and cancer increased in the older age groups, whereas PPV for polyp decreased. On the 
contrary, when abnormal lesions were determined by biopsy results, PPVs of FOBT for polyp, suspicious cancer-
ous lesion, and cancer increased to 32.3%, 60.9%, and 6.3%, respectively (data not shown).
FOBT positive (n) FOBT negative (n) Total (n) Total (%)
Gender
 Male 693,131 8,590,962 9,284,093 45.0
 Female 618,978 10,706,838 11,325,816 55.0
Age group
 50–59 561,217 8,865,910 9,427,127 45.7
 60–69 456,717 6,734,840 7,191,557 34.9
 over 70 294,175 3,697,050 3,991,225 19.4
Year
 2006 90,244 1,074,573 1,164,817 5.7
 2007 101,394 1,286,726 1,388,120 6.7
 2008 125,602 1,706,382 1,831,984 8.9
 2009 143,333 2,137,988 2,281,321 11.1
 2010 180,650 2,613,868 2,794,518 13.6
 2011 196,055 2,861,220 3,057,275 14.8
 2012 227,607 3,655,204 3,882,811 18.8
 2013 247,224 3,961,839 4,209,063 20.4
 Total 1,312,109 19,297,800 20,609,909 100.0
Table 1. Characteristics of study population among the Korea national colorectal cancer screening program 
during 8 years (2006–2013). Abbreviations: FOBT, fecal occult blood test.
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Figure 1. Trends of key indicators in the Korea national colorectal cancer screening program from 2006 to 
2013. (a) Changes in uptake rates (%) of the fecal occult blood test by gender. Uptake rate (%) was calculated as 
follows; Number of fecal occult blood test participants/Number of eligible individuals for national colorectal 
cancer screening program. (b) Changes in fecal occult blood test positivity rates (%) by gender and age group. 
*Comparison of fecal occult blood test positivity rates between males and females and between age groups 
was performed each year using the Chi-square test. All P-values are <0.001. Fecal occult blood test positivity 
rate (%) was calculated as follows; Number of positive fecal occult blood test results/Number of fecal occult 
blood tests performed. (c) Changes in subsequent test compliance rates by gender. Subsequent test compliance 
rate (%) was calculated as follows; Number of colonoscopy or double-contrast barium enema test procedures 
performed/Number of positive fecal occult blood test results.
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Evaluation of colonoscopy procedural performance. A total of 785 side effects were reported within 3 
months period after colonoscopy among 473,960 individuals who underwent colonoscopy (i.e., total SER: 0.17%). 
Among the four categories of side effects, bleeding was the most prevalent side effect in all age groups for both 
genders (Table 3). When the association between old age and incidence of side effects was analyzed, only perfo-
ration showed an increasing pattern in the older age groups with statistical significance (P for trend: <0.001 in 
males and 0.037 in females).
Discussion
The UR, the most classical representative parameter of the national CRC screening program, was higher in 
females than males for all years in this study, which is in line with previous reports from nationwide FOBT 
screening in Scotland4, United Kingdom6, and France7. Considering that there was a higher absolute number of 
women than men in the study population, a higher UR of FOBT screening in Korean women seems obvious and 
might be associated with the fact that men are less likely to take advantage of medical services or to seek health 
advice23.
In contrast to UR, FPR and SCR were higher in males than those in females. Although the higher FPR in 
males can be speculated from the increasing evidence that male gender is a risk factor of CRC24, the higher 
SCR in Korean males than females is an interesting finding. Unfortunately, the plausible underlying reasons for 
the higher willingness of males to comply with further evaluation in the case of a positive FOBT result were 
not explained. However, the paradoxical phenomenon of lower UR, higher FPR, and higher SCR in males than 
females highlights the importance of raising up the UR of males and the necessity of governmental efforts to 
increase it. For females, we suggest that efforts should be focused on increasing SCR rather than UR. One possi-
ble countermeasure to increase UR that can be adapted from a previous study is the use of verbal contact with a 
health professional or the offer of a telephone consultation for colonoscopy25.
When we compare UR, FPR, and SCR results from the Korea national CRC screening program with results of 
other countries, Koreans showed lower UR, higher FPR, and lower SCR than Western populations (i.e., Scotland4, 
United Kingdom6, France7, Italy8, and Finland12) (Supplementary Table 1). Exceptionally, the UR was higher 
in Korea than in some countries (i.e., Canada9, 26, Croatia10, and Spain11), and FPR was comparable to that of 
Croatia10. Since these three parameters might be affected by cultural atmosphere and national concern for health 
in the public, it would be more appropriate to compare key indicators of the national CRC program with those 
from adjacent Asian countries. Due to the relative scarcity of these systematic studies performed in East Asian 
countries27 compared to Western countries, our study might serve as a milestone for assessing racial or ethnic 
effects on UR, FPR, and SCR in national CRC screening programs of different countries.
At the same time, distinctive findings revealed in this study should be considered in the future directions 
for domestic improvement of the Korea national CRC screening program. Because UR and SCR play crucial 
roles in successful implementation of a nationwide CRC screening program, we suggest that various efforts and 
focused plans to efficiently increase UR and SCR are required. Moreover, changes in UR, FPR, and SCR over 
time should also be considered. Considering the change from biennial FOBT uptake to annual FOBT uptake in 
2012, the increase in UR from 2006 to 2011 and the similar increase from 2012 to 2013 is expected to continue 
although no special improvements or promotion have been implanted during the study period. The decrease 
in FPR from 2006 to 2013 might be stabilized with nationwide standardization of FOBT modality. We suggest 
that the time-dependent analysis of key indicators for evaluation of successful national CRC screening program 
implementation should be followed into the future.
A recent study by Spanish researchers presents an excellent example of evaluation for key performance indi-
cators in national CRC screening program28. A significant rise in the detection rate for high-risk adenoma in 
Spanish men was highlighted in that study, which highlights the importance of consistent and accurate monitor-
ing for key indicators of the nationwide CRC screening program. Although such approach was not available in 
our study, further evaluation utilizing several factors suggested in the previous study28, including time to colonos-
copy and cancer stage classification, should be considered in the future Korean national CRC screening program.
The evaluation of the diagnostic utility of FOBT in the Korea national CRC screening program was another 
purpose of this study to assess the successful implementation of the program. Although both quantitative and 
qualitative methods were utilized in the screening program, the PPVs for suspicious cancerous lesion and cancer 
(%) polyp suspicious cancerous lesion* cancer
Total 21.4 42.6 1.3
Gender
 Male 18.2 50.7 1.6
 Female 24.8 33.8 1.0
Age group
 50–59 23.4 38.2 0.8
 60–69 20.3 44.9 1.5
 over 70 18.4 49.0 2.2
Table 2. Predictive value of positive test of fecal occult blood test according to colonoscopy or double-contrast 
barium enema results. *Suspicious cancer lesions were categorized in the database based on individual 
physicians’ descriptions to express wide spectrum between definitive polyp and definitive cancer, possibly 
including inflammatory or high-grade dysplastic lesions that required further biopsy procedure.
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were all higher in males than females, which is in line with previous results23 and with the evidence of the higher 
CRC incidence in men24. Compared to PPVs analyzed in other countries, PPVs for cancer in Korea appear to be 
lower, even when compared with values using biopsy results. Nevertheless, PPVs for polyp and suspicious cancer-
ous lesion were higher than those calculated in other countries. Considering the ultimate objective of the screen-
ing step, comparable PPVs calculated in this study demonstrate that FOBT performed in the Korea national CRC 
screening program from 2006 to 2013 showed appropriate diagnostic specification. However, a more careful 
follow-up study is required since different modalities of FOBT (i.e., guaiac-based or immunochemical FOBT) 
can affect the PPVs in different CRC screening programs29, 30. When financial resources and environmental avail-
ability are taken into account, we suggest that a uniformly standardized FOBT modality should be introduced in 
the future CRC screening in Korea.
One important result of this study that is unique compared to results from other population-based CRC 
screening reports is the SER analysis in subsequent colonoscopy performed for individuals with positive FOBT 
results. Since colonoscopy is a confirmative test, explanation on the side effects of the procedure should be offered 
to participants in advance. Although the quality of performing physicians varies enormously depending on coun-
try and district, the potentially life-threatening risks of colonoscopy such as perforation and bleeding must be 
evaluated in order to apply this procedure to the national population. In terms of overall morbidity, the total 
SER in this study (0.17%) was lower than those of United Kingdom (0.44%)31, Germany (0.28%)5, Australia 
(0.3%)32, and France (0.23%)7. This finding indicates that the safety and proficiency of colonoscopy in the current 
Korea national CRC screening program are equivalent to or even better than those of other countries. Our results 
indicate that males are more prone to the side effects of colonoscopy than females, irrespective of complication 
type. Another interesting finding regarding SER in this study is that the side effects of perforation and bleeding 
occurred more frequently in the older age groups. In contrast, infection related to colonoscopy did not show any 
specific association with age or gender. Based on these results, we suggest that more caution to prevent perfo-
ration or bleeding should be exerted by performing physicians, especially in the evaluation of old male partici-
pants in the Korea national CRC screening program. Lastly, this study represents the most updated information 
for Korean population encompassing the period when change of required interval for follow-up screening test 
occurred, whereas other previous studies limited the study period to 5 years17, 33. Focusing on gender-specific 
trends over 8 years, our study highlights the importance of gender-specific approach in order to improve the key 
indicators in the national CRC screening program efficiently.
There are several limitations of this study. Firstly, the heterogeneity of the FOBT modalities utilized in this 
study could have affected the analysis. Although a total proportion of quantitative and qualitative test in the total 
population was available, the precise modalities of each individual were not collected in the original database 
unfortunately, due to various environments of clinical laboratories at multiple centers located throughout Korea. 
However, the interpretation of positive or negative results was reported according to the corresponding modal-
ities. Secondly, the performance of colonoscopy or DCBE could not be standardized because the test centers 
were also scattered throughout the country. Thirdly, as mentioned before, the histopathological assessment was 
missing in the database which precluded us from investigating the true PPV values based on pathologic results. 
However, it would still be valuable to estimate at least the maximum PPV of FOBT since the true PPVs are obvi-
ously lower than our calculated PPVs based on colonoscopy results. Fourthly, characteristics of abnormal lesions 
detected in colonoscopy such as size and location could not be thoroughly investigated for association with FOBT 
results due to incomplete data in the screening program. Furthermore, data collection for adverse events via 
classification tools might have underestimated SER due to subjective reporting by individual clinicians. Although 
the major complications have been elucidated in this study, cautious interpretation for the absolute SER values is 
required especially when comparing these numbers with other datasets. Finally, socioeconomic deprivation status 
of participants, which has recently been suggested to be related with low UR and low SCR34, was not analyzed in 
the present study due to the lack of data.
In conclusion, this study presents the largest dataset from a nationwide CRC screening program. Since degrees 
of participation and subsequent test compliance were as low as other countries, there appear to be several points 
for improvement in the future amendments of national CRC screening, such as special efforts to increase the UR 
in males. Trends of key indicators for Korea national CRC screening program should be monitored continuously, 
in accordance with the Korean-specific characteristics of the CRC and the national screening program itself, 
which were revealed in this study.
Gender Male Female
Male Female P valueAge group 50–59 60–69 over 70 P for trend 50–59 60–69 over 70 P for trend
Bleeding 107 (0.10) 97 (0.11) 67 (0.15) 0.013 47 (0.04) 54 (0.07) 21 (0.05) 0.156 271 (0.11) 122 (0.05) <0.001
Perforation 68 (0.06) 86 (0.10) 59 (0.13) <0.001 30 (0.03) 32 (0.04) 19 (0.05) 0.037 213 (0.09) 81 (0.04) <0.001
Infection 27 (0.02) 13 (0.01) 11 (0.02) 0.621 13 (0.01) 8 (0.01) 4 (0.01) 0.735 51 (0.02) 25 (0.01) 0.007
Others 5 (0.00) 7 (0.01) 3 (0.01) 0.510 4 (0.00) 2 (0.00) 1 (0.00) 0.674 15 (0.01) 7 (0.00) 0.121
Table 3. Events of side effects occurred within 3 months after colonoscopy according to gender and age group. 
Values are presented in units of number (%). Corresponding Korean Classification of Diseases (KCD) codes 
that had been input in the Korean National Health Insurance Service (KNHIS) database within 3 months 
period after colonoscopy for each category are as follows; bleeding: hemorrhage, and hematoma; perforation: 
injury, traumatic perforation, and accidental perforation; infection: infection following a procedure; others: air 
embolism, shock resulting from a procedure, and complications of surgical and medical care.
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